Attaching herewith the report on “ Top 50 Pharma” published by Pharmaceutical Executive Magazine. Pfizer continues to be at Numero Uno position and crossed the US$ 50 billion mark in global sales with acquisition of Wyeth. Our own Merck KGaA is at 21st rank.
Global pharma sales growth is driven by Latin America-16.3% and 3As (Asia/Africa/Australia) – 13.3%. Europe and North America continues to witness sluggish growth.
Oncology retained its number one position in value sales by Therapeutic Classes and Lupid Regulators managed to hold on their number one position in prescriptions sales by Therapeutic Classes.
It is interesting to note that by recent estimate by PWC, Indian Domestic Pharma market would be between US$ 50-75 billion by 2020. India has plenty of catch-up to do!!!!!!!!
Hope you will enjoy reading this insightful report.